| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |